[Pubmed] Study on the clinical and electrophysiological characteristics of nerve function in myasthenia gravis patients

[RSS-Bot]

SAGE Open Med. 2024 Mar 25;12:20503121241229591. doi: 10.1177/20503121241229591. eCollection 2024.

ABSTRACT

BACKGROUND: In Vietnam, there is limited research on the role of nerve conduction in myasthenia gravis and its association with clinical features.

OBJECTIVE: This study aims to describe the electrophysiological features in patients with myasthenia gravis.

METHODS: This descriptive study was conducted from September 2019 to December 2021. The study included 33 myasthenia gravis patients who sought medical consultation or received inpatient treatment during this period. The Myasthenia Gravis Foundation of America classifies myasthenia gravis into five groups: I, IIa, IIb, IIIa, IIIb, IVa, IVb, and V. Notably, Group I involves pure ocular weakness, whereas Group a primarily impacts limb and axial muscles, and Group b mainly affects bulbar and respiratory muscles.

RESULTS: The study revealed that motor and sensory nerve conduction in the upper and lower limbs were within normal limits for the patient group under evaluation. Repetitive nerve stimulation testing at a frequency of 3 Hz showed positive results in 66.7% of myasthenia gravis patients. Myasthenia gravis patients displayed distinct clinical symptoms, with ptosis being the most common (87.9%). Myasthenia Gravis Foundation of America classification indicated the highest proportion in subgroup IIa (24.2%), with myasthenia gravis predominating in limb and axial muscles (Group a) observed in 51.5% of cases. Needle electromyography showed no abnormalities in myasthenia gravis patients. There was an association between acetylcholine receptor antibody titers and the results of the 3 Hz repetitive nerve stimulation test in myasthenia gravis patients, with a significance of p = 0.002.

CONCLUSION: Nerve conduction studies should be performed in patients with suspected neuromuscular disorders to aid in differential diagnosis and definitive diagnosis of myasthenia gravis.

PMID:38533199 | PMC:PMC10964451 | DOI:10.1177/20503121241229591


Source: https://pubmed.ncbi.nlm.nih.gov/3853319 ... t9+e462414